Bortezomib facilitates the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/ Her2-targeted CAR-NK-92 cells via upregulation of DR5
Article (June 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article (June 2024)
Article in Nature Communications (March 2024)
Preprint in bioRxiv (January 2024)